Cargando…

Effectiveness and safety of basal insulin therapy in type 2 diabetes mellitus patients with or without metformin observed in a national cohort in China

BACKGROUND: Though many randomized control trials had examined the effectiveness and safety of taking insulin therapy with or without metformin, there are limited real-world data, especially among Chinese type 2 diabetes patients initiating basal insulin (BI) with uncontrolled hyperglycemia by oral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Puhong, Chen, Minyuan, Zhang, Heng, Luo, Yingying, Zhu, Dongshan, Li, Xian, Ji, Jiachao, Wang, Du, Duolikun, Nadila, Ji, Linong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767735/ https://www.ncbi.nlm.nih.gov/pubmed/35045841 http://dx.doi.org/10.1186/s12902-021-00892-6

Ejemplares similares

Where to Initiate Basal Insulin Therapy: Inpatient or Outpatient Department? Real-World Observation in China
por: Chen, Minyuan, et al.
Publicado: (2022)

Changes of health-related quality of life after initiating basal insulin treatment among people with type 2 diabetes
por: Zhang, Puhong, et al.
Publicado: (2023)

Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus
por: Zhang, Puhong, et al.
Publicado: (2020)

Road to Hierarchical Diabetes Management at Primary Care (ROADMAP) Study in China: Protocol for the Statistical Analysis of a Cluster Randomized Controlled Trial
por: Li, Xian, et al.
Publicado: (2020)

Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial
por: Jia, Weiping, et al.
Publicado: (2021)

Study protocol for the road to hierarchical diabetes management at primary care (ROADMAP) study in China: a cluster randomised controlled trial
por: Jia, Weiping, et al.
Publicado: (2020)

Medical costs and out-of-pocket expenditures associated with multimorbidity in China: quantile regression analysis
por: Zhao, Yang, et al.
Publicado: (2021)

Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
por: Kang, Yu Mi, et al.
Publicado: (2019)

Analysis of Insulin Doses of Chinese Type 2 Diabetic Patients with Intensive Insulin Treatment
por: Cai, Xiaoling, et al.
Publicado: (2012)

Successful Treatment with Bedtime Basal Insulin Added to Metformin without Weight Gain or Hypoglycaemia over Three Years
por: Mertes, Bernardo, et al.
Publicado: (2020)

Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia
por: Ji, Linong, et al.
Publicado: (2019)

A pragmatic study of mid‐mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real‐world experience
por: Zhang, Xiaomei, et al.
Publicado: (2020)

Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double‐blind, placebo‐controlled study
por: Ji, Linong, et al.
Publicado: (2021)

Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK
por: McCrimmon, Rory J., et al.
Publicado: (2021)

Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China
por: Cai, Xiaoling, et al.
Publicado: (2020)

First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
por: TSAI, Shih-Tzer, et al.
Publicado: (2011)

Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co‐administered to Chinese patients with type 2 diabetes mellitus
por: Ji, Linong, et al.
Publicado: (2016)

The prevalence of multimorbidity and its association with physical activity and sleep duration in middle aged and elderly adults: a longitudinal analysis from China
por: He, Li, et al.
Publicado: (2021)

Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Cai, Xiaoling, et al.
Publicado: (2021)

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled trial
por: Ahmann, A., et al.
Publicado: (2015)

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?
por: Saleh, Hend S., et al.
Publicado: (2016)

Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China
por: Liu, Guangxu, et al.
Publicado: (2018)

Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis
por: Guo, Lanlan, et al.
Publicado: (2019)

A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World Experience
por: Zeng, Tianshu, et al.
Publicado: (2021)

Efficacy and Safety of Linagliptin Co-Administered with Low-Dose Metformin Once Daily Versus High-Dose Metformin Twice Daily in Treatment-Naïve Patients with Type 2 Diabetes: a Double-Blind Randomized Trial
por: Ji, Linong, et al.
Publicado: (2015)

The clinical implications of fasting serum insulin levels in patients with insulin-treated type 2 diabetes: a cross-sectional survey
por: Zhou, Lingli, et al.
Publicado: (2023)

Provincial heterogeneity in the management of care cascade for hypertension, diabetes, and dyslipidaemia in China: Analysis of nationally representative population-based survey
por: Zhao, Yang, et al.
Publicado: (2022)

Effects of insulin aspart and metformin on gestational diabetes mellitus and inflammatory markers
por: Wang, Yan, et al.
Publicado: (2023)

Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes
por: Shankar, R Ravi, et al.
Publicado: (2016)

Once Weekly Basal Insulin Fc (BIF) is Safe and Efficacious in Patients with Type 2 Diabetes Mellitus (T2DM) Previously Treated With Basal Insulin
por: Frias, Juan Pablo, et al.
Publicado: (2021)

Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus
por: Wu, Honghua, et al.
Publicado: (2017)

The effectiveness of postpartum interventions aimed at improving women’s mental health after medical complications of pregnancy: a systematic review and meta-analysis
por: Shang, Jie, et al.
Publicado: (2022)

National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia Registry
por: Ji, Linong, et al.
Publicado: (2015)

Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus
por: Jin, Hongmei, et al.
Publicado: (2022)

A Guideline-Based Decision Tree Achieves Better Glucose Control with Less Hypoglycemia at 3 Months in Chinese Diabetic Patients
por: Luo, Yingying, et al.
Publicado: (2021)

Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity
por: Ji, Linong, et al.
Publicado: (2023)

Analysis on the Effect of Metformin Hydrochloride Combined with Insulin Pump for Gestational Diabetes Mellitus
por: Li, Xinghua, et al.
Publicado: (2022)

Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study
por: Hirose, Takahisa, et al.
Publicado: (2015)

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q9hoka82jmh9takalu2vnsh9ci